|
Volumn 78, Issue 3, 2011, Pages 376-384
|
Efficacy and safety of glycoprotein IIb/IIIa receptor antagonists for patients undergoing percutaneous coronary intervention within twelve hours of fibrinolysis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
FIBRINOGEN RECEPTOR;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
BLEEDING;
CHEMICALLY INDUCED DISORDER;
CHI SQUARE DISTRIBUTION;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
FEMALE;
FIBRINOLYTIC THERAPY;
FRANCE;
HEART INFARCTION;
HUMAN;
KAPLAN MEIER METHOD;
MALE;
MIDDLE AGED;
MORTALITY;
PATIENT SELECTION;
PROPENSITY SCORE;
RADIOGRAPHY;
RECURRENT DISEASE;
REGISTER;
RISK;
RISK ASSESSMENT;
RISK FACTOR;
STATISTICAL MODEL;
STROKE;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
AGED;
ANGIOPLASTY, BALLOON, CORONARY;
CHI-SQUARE DISTRIBUTION;
CORONARY ANGIOGRAPHY;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FRANCE;
HEMORRHAGE;
HOSPITAL MORTALITY;
HUMANS;
KAPLAN-MEIER ESTIMATE;
LOGISTIC MODELS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
ODDS RATIO;
PATIENT SELECTION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PROPENSITY SCORE;
RECURRENCE;
REGISTRIES;
RISK ASSESSMENT;
RISK FACTORS;
STROKE;
THROMBOLYTIC THERAPY;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84856471154
PISSN: None
EISSN: 1522726X
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|